Vancomycin-resistant enterococci: 15 years and counting

Journal of Hospital Infection

Volumn 53, Issue 3, 2003, Pages 159-171

  Chavers, L S ^a   Moser, S A ^a   Benjamin Jr , W H ^a   Banks, S E ^a   Steinhauer, J R ^a   Smith, A M ^a   Johnson, C N ^a   Funkhouser, E ^a   Chavers, L P ^a   Stamm, A M ^b   Waites, Ken B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobials; Enterococci; Resistance; Vancomycin

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METICILLIN; NITROFURANTOIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE; TICARCILLIN; TIMENTIN; TRIMETHOPRIM; UNINDEXED DRUG; UREIDOPENICILLIN DERIVATIVE; VANCOMYCIN; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLINICAL FEATURE; CLONAL VARIATION; DISEASE ACTIVITY; DISEASE CARRIER; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; ENTEROCOCCUS; EXPOSURE; GENE MUTATION; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MODEL; NONHUMAN; PREVALENCE; REVIEW; TEACHING HOSPITAL; TREATMENT PLANNING; URBAN AREA; CLASSIFICATION; CROSS INFECTION; EPIDEMIC; EPIDEMIOLOGY; GENETICS; HETEROZYGOTE; INCIDENCE; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYLOGENY; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; STATISTICS;

CARRIER STATE; CAUSALITY; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE RESERVOIRS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; PHYLOGENY; POPULATION SURVEILLANCE; SEROTYPING; VANCOMYCIN RESISTANCE;

EID: 0038312007     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2002.1375     Document Type: Review

References (117)

1. Leclercq, R, Derlot, E, Duval, J, Courvalin, P (1988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med, 319 157-161.
2. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995; 23: 87-94.
3. Uttley, AH, Collins, CH, Naidoo, J, George, RC (1988). Vancomycin-resistant enterococci. Lancet, 1 57-58.
4. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morb Mortal Wkly Rep1993; 42: 597-599.
5. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999. Am J Infect Control 1999; 27: 520-532.
6. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001. Am J Infect Control 2001; 29: 404-42l.
7. Vergis, EN, Hayden, MK, Chow, JW et al. (2001). Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia a prospective multicenter study. Ann Intern Med, 135 484-492.
8. Stosor, V, Peterson, LR, Postelnick, M, Noskin, GA (1998). Enterococcus faecium bacteremia: does vancomycin resistance make a difference?. Arch Intern Med, 158 522-527.
9. Garbutt, JM, Ventrapragada, M, Littenberg, B, Mundy, LM (2000). Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis, 30 466-472.
10. Lautenbach, E, Bilker, WB, Brennan, PJ (1999). Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol, 20 318-323.
11. Hiramatsu, K (1998). The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med, 104 7S-10S.
12. Arthur, M, Courvalin, P (1993). Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother, 37 1563-1571.
13. Heaton, MP, Handwerger, S (1995). Conjugative mobilization of a vancomycin resistance plasmid by a putative Enterococcus faecium sex pheromone response plasmid. Microb Drug Resist, 1 177-183.
14. Diekema, DJ, Pfaller, MA, Schmitz, FJ et al. (2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the-SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis, 32 S114-S132.
15. Tenover, FC, Biddle, JW, Lancaster, MV (2001). Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis, 7 327-332.
16. Perl, TM (1999). The threat of vancomycin resistance. Am J Med, 106 26S-37S.
17. Staphylococcus aureus resistant to vancomycin - United States, 2002. Morb Mortal Wkly Rep 2002; 51: 565-567.
18. Huycke, M, Sahm, D, Gilmore, S (1998). Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis, 4 1218-1231.
19. Freeman, R, Kearns, AM, Lightfoot, NF (1994). Heat resistance of nosocomial enterococci. Lancet, 344 64-65.
20. Kearns, AM, Freeman, R, Lightfoot, NF (1995). Nosocomial enterococci: resistance to heat and sodium hypochlorite. J Hosp Infect, 30 193-199.
21. Noskin, GA, Stosor, V, Cooper, I, Peterson, LR (1995). Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol, 16 577-581.
22. Wade, JJ (1995). The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - a preliminary report. J Hosp Infect, 30 483-493.
23. Morris, Jr. JG, Shay, DK, Hebden, JN et al. (1995). Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med, 123 250-259.
24. Boyce, JM, Opal, SM, Chow, JW (1994). Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol, 32 1148-1153.
25. Edmond, M, Ober, J, Weinbaum, D et al. (1995). Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis, 20 1134-1136.
26. Bonilla, HF, Zervos, MA, Lyons, MJ et al. (1997). Colonization with vancomycin-resistant Enterococcus faecium comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol, 18 333-339.
27. Boyce, JM, Mermel, LA, Zervos, MJ et al. (1995). Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol, 16 634-637.
28. Livornese, LL J, Dias, S, Samel, C (1992). Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med, 117 112-116.
29. Porwancher, R, Sheth, A, Remphrey, S, Taylor, E, Hinkle, C (1997). Epidemiologic study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer. Infect Control Hosp Epidemiol, 18 771-773.
30. Karanfil, LV, Murphy, M, Josephson, A (1993). A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol, 13 195-200.
31. Falk, PS, Winnike, J, Woodmansee, C, Desai, M, Mayhall, CG (2000). Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol, 21 575-582.
32. Gould, FK, Freeman, R (1995). Nosocomial infection with microsphere beds. Lancet, 342 241-242.
33. Wilcox, MH, Jones, BL (1993). Enterococci and hospital laundry. Lancet, 345-594.
34. Slaughter, S, Hayden, MK, Nathan, C et al. (1996). A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med, 125 448-456.
35. Mato, R, de Lencastre, H, Roberts, RB, Tomasz, A (1996). Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital. Microb Drug Resist, 2 309-317.
36. Freeman, R, Gould, FK, Ryan, DW, Chamberlain, J, Sisson, PR (1994). Nosocomial infection due to enterococci attributed to a fluidized microsphere bed. The value of pyrolysis mass spectrometry. J Hosp Infect, 27 187-193.
37. Murray, B (1998). Diversity among multidrug-resistant enterococci. Emerg Infect Dis, 4 34-47.
38. Low, DE, Keller, N, Barth, A, Jones, RN (2001). Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis, 32 S133-S145.
39. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000; 28: 429-448.
40. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance report, data summary from January 1996 through December 1997: a report fromthe National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1999; 27: 279-284.
41. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26: 522-533.
42. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997. A report from the NNIS System. Am J Infect Control 1997; 25: 477-487.
43. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996; 24: 380-388.
44. Martone, WJ, Gaynes, RP, Horan, TC et al. (1995). National Nosocomial Infections Surveillance (NNIS) semiannual report, May 1995. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control, 23 377-385.
45. Nosocomial infection rates for interhospital comparison: limitations and possible solutions. A Report from the National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 1991;12: 609-621.
46. Mundy, LM (1998). Enterococci: susceptibility, resistance, and now dependence on vancomycin. Am J Clin Pathol, 109 367-370.
47. Jones, RN, Marshall, SA, Pfaller, MA (1997). Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis, 29 95-102.
48. Edmond, MB (1997). Multidrug-resistant enterococci and the threat of vancomycin resistant Staphylococcus aureus. In RP Wenzel (Ed.), Prevention and Control of Nosocomial Infections, 339-355. Baltimore: Williams & Wilkins.
49. Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP (1996). Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis, 23 1234-1239.
50. Murray, B (1996). Enterococci: How to make a second-rate pathogen into a first-rate problem. Program and Abstracts, 34th Annual meeting of the Infectious Diseases Society of America, New Orleans, LA; 1996; 339.
51. Murray, BE (1990). The life and times of the Enterococcus. Clin Microbiol Rev, 3 46-65.
52. Murray, BE (1997). Vancomycin-resistant enterococci. Am J Med, 101 284-293.
53. Rice, LB (2001). Emergence of vancomycin-resistant enterococci. Emerg Infect Dis, 7 183-187.
54. Cetinkaya, Y, Falk, P, Mayhall, CG (2000). Vancomycin-resistant enterococci. Clin Microbiol Rev, 13 686-707.
55. Donskey, CJ, Rice, LB (1999). The influence of antibiotics on spread of vancomycin-resistant enterococci: the potential role of selective use of antibiotics as a control measure. Clin Microbiol Newsletter, 23 1020-1025.
56. Prystowsky, J, Siddiqui, F, Chosay, J et al. (2001). Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother, 45 2154-2156.
57. Karlowsky, JA, Zhanel, GG, Hoban, DJ (1999). Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Canadian VRE Surveillance Group. Diagn Microbiol Infect Dis, 35 1-7.
58. Leclercq, R (1998). Heterospecific transfer and expression of enterococcal resistance to glycopeptides. In C Brun-Buisson, G Eliopoulos, & R Leclercq (Eds.), Bacterial Resistance to Glycopeptides, 39-46. Paris: Medecine-Sciences Flammarion.
59. Boyce, JM, Opal, SM, Chow, JW et al. (1994). Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol, 32 1148-1153.
60. Bonten, MJ, Hayden, MK, Nathan, C et al. (1996). Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet, 348 1615-1619.
61. Tornieporth, NG, Roberts, RB, John, J, Hafner, A, Riley, LW (1996). Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis, 23 767-772.
62. Rubin, LG, Tucci, V, Cercenado, E, Eliopaulos, G, Isenberg, HD (1992). Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol, 13 700-705.
63. Pittet, D, Mourouga, P, Perneger, TV (1999). Compliance with handwashing in a teaching hospital. Infection Control Program. Ann Intern Med, 130 126-130.
64. Bates, J, Jordens, Z, Selkon, JB (1993). Evidence for an animal origin of vancomycin-resistant enterococci. Lancet, 342 490-491.
65. Kampf, G, Hofer, M, Wendt, C (1999). Efficacy of hand disinfectants against vancomycin-resistant enterococci in vitro. J Hosp Infect, 42 143-150.
66. Klare, I, Badstubner, D, Konstabel, C, Bohme, G, Claus, H, Witte, W (1999). Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist, 5 45-52.
67. Klare, I, Heier, H, Claus, H, Reissbrodt, R, Witte, W (1995). vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett, 125 165-171.
68. Klare, I, Heier, H, Claus, H et al. (1995). Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist, 1 265-272.
69. Witte, W, Klare, I (1995). Glycopeptide-resistant Enterococcus faecium outside Hospitals: a commentary. Microb Drug Resist, 1 259-263.
70. Aarestrup, FM (1995). Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist, 1 255-257.
71. Jordens, JZ, Bates, J, Griffiths, DT (1994). Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother, 34 515-528.
72. Montecalvo, MA (1995). Natural history of colonization with vancomycin resistant Enterococcus. Infect Control Hosp Epidemiol, 16 680-685.
73. Papanicolaou, GA, Meyers, BR, Meyers, J et al. (1996). Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis, 23 760-766.
74. Donskey, CJ, Schreiber, JR, Jacobs, MR et al. (1999). A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis, 29 573-579.
75. Harbarth, S, Cosgrove, S, Carmeli, Y (2002). Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother, 46 1619-1628.
76. Lam, S, Singer, C, Tucci, V, Mothland, VH, Pfaller, MA, Isenberg, HD (1995). The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control, 23 170-180.
77. Beezhold, DW, Slaughter, S, Hayden, MK et al. (1997). Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis, 24 704-706.
78. Boyle, JF, Soumakis, SA, Rendo, A et al. (1993). Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol, 31 1280-1285.
79. D'Agata, EM, Green, WK, Schulman, G, Li, H, Tang, YW, Schaffner, W (2001). Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis, 32 23-29.
80. Newell, KA, Millis, JM, Arnow, PM et al. (1998). Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation, 65 439-442.
81. Orloff, SL, Busch, AM, Olyaei, AJ et al. (1999). Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg, 177 418-422.
82. Peset, V, Tallon, P, Sola, C et al. (2000). Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis, 19 742-749.
83. Rao, GG, Ojo, F, Kolokithas, D (1997). Vancomycin-resistant Gram-positive cocci: risk factors for faecal carriage. J Hosp Infect, 35 63-69.
84. Shay, DK, Maloney, SA, Montecalvo, M et al. (1995). Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis, 172 993-1000.
85. Singh-Naz, N, Sleemi, A, Pikis, A, Patel, KM, Campos, JM (1999). Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol, 37 413-416.
86. Dembry, LM, Uzokwe, K, Zervos, MJ (1996). Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol, 17 286-292.
87. McManus, AT, Goodwin, CW, Pruitt, Jr. BA (1998). Observations on the risk of resistance with the extended use of vancomycin. Arch Surg, 133 1207-1211.
88. Ostrowsky, BE, Trick, WE, Sohn, AH et al. (2001). Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med, 344 1427-1433.
89. Ostrowsky, BE, Venkataraman, L, D'Agata, EM, Gold, HS, DeGirolami, PC, Samore, MH (1999). Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med, 159 1467-1472.
90. Pfundstein, J, Roghmann, MC, Schwalbe, RS et al. (1999). A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. Clin Transplant, 13 245-252.
91. Donskey, CJ, Hoyen, CK, Das, SM, Farmer, S, Dery, M, & Bonomo, RA (2001). Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol, 33 84-88.
92. Toye, B, Shymanski, J, Bobrowska, M, Woods, W, Ramotar, K (1997). Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype) [published erratum appears in J Clin Microbiol 1998; 36: 1469]. J Clin Microbiol, 35 3166-3170.
93. Trabulsi, A, Glover, AM, Reising, SF, Christie, CD (1998). Absence of rectal colonization with vancomycin-resistant enterococci among high-risk pediatric patients. Infect Control Hosp Epidemiol, 19 109-112.
94. Wendt, C, Krause, C, Xander, LU, Loffler, D, Floss, H (1999). Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany. J Hosp Infect, 42 193-200.
95. Carmeli, Y, Samore, MH, Huskins, C (1999). The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med, 159 2461-2468.
96. Chavers, S, Moser, S, Benjamin, W, Chavers, P, Stamm, A, Waites, K (2001). Antibiotic exposure as a risk factor for development of vancomycin-resistant Enterococcus. Program and Abstracts, 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL; 2001; UL12.
97. Dahms, RA, Johnson, EM, Statz, CL, Lee, JT, Dunn, DL, Beilman, GJ (1998). Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection. Arch Surg, 133 1343-1346.
98. Loeb, M, Salama, S, Armstrong-Evans, M, Capretta, G, Olde, J (1999). A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol, 20 760-763.
99. Montecalvo, MA, Horowitz, H, Gedris, C (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother, 38 1363-1367.
100. Moreno, F, Grota, P, Crisp, C et al. (1995). Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis, 21 1234-1237.
101. Moulin, F, Dumontier, S, Saulnier, P et al. (1996). Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. Clin Microbiol Infect, 2 192-201.
102. Nourse, C, Murphy, H, Byrne, C et al. (1998). Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation [published erratum appears in Eur J Pediatr 1998; 157: 405]. Eur J Pediatr, 157 20-27.
103. Quale, J, Landman, D, Saurina, G, Atwood, E, DiTore, V, Patel, K (1996). Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis, 23 1020-1025.
104. Bradley, SJ (2000). Control of glycopeptide-resistant enterococci in an oncology unit. Pharmacotherapy, 20 203S-212S.
105. Smith, DW (1999). Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy, 19 129S-132S.
106. May, K, Melton, SM, McGwin, G, Cross, JM, Moser, SA, Rue, LW (2000). Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock, 14 259-264.
107. Donskey, CJ, Chowdhry, TK, Hecker, MT et al. (2000). Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med, 343 1925-1932.
108. Lucas, GM, Lechtzin, N, Puryear, DW, Yau, LL, Flexner, CW, Moore, RD (1998). Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis, 26 1127-1133.
109. Pegues, DA, Pegues, CF, Hibberd, PL, Ford, DS, Hooper, DC (1997). Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol, 35 1565-1570.
110. Tokars, JI, Satake, S, Rimland, D et al. (1999). The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution. Infect Control Hosp Epidemiol, 20 171-175.
111. Donskey, CJ, Hanrahan, JA, Hutton, RA, Rice, LB (1999). Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis, 180 384-390.
112. Korten, V, Murray, BE (1993). Impact of the fluoroquinolones on gastrointestinal flora. Drugs, 45 125-133.
113. Bonten, MJ, Slaughter, S, Ambergen, AW et al. (1998). The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med, 158 1127-1132.
114. Green, M, Barbadora, K, Michaels, M (1991). Recovery of vancomycin-resistant Gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol, 29 2503-2506.
115. Lai, KK, Kelley, AL, Melvin, ZS, Belliveau, PP, Fontecchio, SA (1998). Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol, 19 647-652.
116. Wade, J, Baillie, L, Rolando, N, Casewell, M (1992). Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin. Lancet, 339 312-331.
117. National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing: 12th Informational Supplement, Wayne, PA, NCCLS, 2002